Practice and prospect of non drug therapy for inflammatory bowel disease

doi:10.3877/cma.j.issn.2095-2015.2017.01.001

Abstract

Abstract:

Stem cell transplantation, selective granulocyte and monocyte apheresis, human fecal microbiota transplantation and other non conventional drugs for treatment of some refractory inflammatory bowel disease achieves a certain effect, and has certain application prospects.But which patients are suitable for use, how to use, security and other issues have not been completely resolved.This review introduces the practice and prospect of the methods.

Key words: Inflammatory bowel diseases, Stem cell transplantation, sSelective granulocyte and monocyte apheresis, Fecal microbiota transplantation

Xueliang Jiang. Practice and prospect of non drug therapy for inflammatory bowel disease[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2017, 07(01): 1-3.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxhbyyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2015.2017.01.001

https://zhxhbyyxzz.cma-cmc.com.cn/EN/Y2017/V07/I01/1

References 19

1	江学良．溃疡性结肠炎治疗中应注意的几个问题[J/CD]．中华消化病与影像杂志(电子版)，2015，5(5)：211-213.
2	Bender E. Cell-based therapy: Cells on trial[J]. Nature, 2016, 540(7634): S106-S108.
3	江学良．非清髓脐带血干细胞治疗激素抵抗型溃疡性结肠炎临床研究[J]．中华消化内镜杂志，2010，27(8)：423-426.
4	江学良，崔慧斐．顽固性溃疡性结肠炎治疗的新方法[J]．世界华人消化杂志，2011，19(18)：1871-1873.
5	Dave M, Mehta K, Luther J, et al.Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis[J]. Inflam Bow Dis, 2015, 21(11): 2696-2707.
6	Colman RJ, Rubin DT.Fecal microbiota transplantation as herapy for inflammatory bowel disease: A systematic review and meta-analysis [J]. J Crohns Colitis, 2014, 8(12): 1569-1581.
7	Surawicz CM, Brandt LJ, Binon DG, et al.Guidelines for diagnosis, treatment, and prevention of Clostridiu difficile infections[J]. Am J Gastroenterol, 2013, 108(4): 478-498.
8	郑晗晗，江学良．粪便菌群移植治疗艰难梭菌感染有效性和安全性的Meta分析[J]．中国全科医学，2016，19(2)：199-205.
9	孙橙橙，江学良．粪菌移植在溃疡性结肠炎治疗中的临床应用[J]．临床荟萃，2016，31(8)：838-842.
10	Owens C, Broussard E, Surawicz C. Fecal microbiota transplantation and donor standardization [J]. Trends Microbiol, 2013, 21(9): 443-445.
11	Rubin DT, Kirsner JB.Fecal microbiota transplantation for the treatment of inflammatory bowel disease [J]. Gastroenterol Hepatol, 2015, 11(9): 618-620.
12	Sun D, Li W, Li S, et al.Fecal microbiota transplantation as a novel therapy for ulcerative colitis: A systematic review and Meta-analysis[J]. Medicine, 2016, 95(23): e3765.
13	Scaldaferri F, Pecere S, Petito V, et al.Efficacy and mechanisms of action of fecal microbiota transplantationin ulcerative colitis: pitfalls and promises from a first Meta-analysis[J]. Transplant Proc, 2016, 48(2): 402-407.
14	Wei Y, Zhu W, Gong J, et al.Fecal microbiota transplantation improves the quality of life in patients with inflammatory bowel disease[J]. Gastroenterol Res Pract, 2015, 2015: 517597.
15	江学良，崔云龙，张宗梅，等．粪菌移植的研究现状、存在问题与发展方向[J/CD]．中华消化病与影像杂志(电子版)，2014，4(4)：152-155.
16	Colman RJ, Rubin DT.Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis[J]. J Crohns Colitis, 2014, 8(12): 1569-1581.
17	Manichanh C, Borruel N, Casellas F, et al.The gut microbiota in IBD[J]. Nat Rev Gastroenterol Hepatol, 2012, 9(10): 599-608.
18	王海秀，江学良．选择性白细胞吸附疗法在治疗炎症性肠病中的应用[J]．医学新知杂志，2015，25(4)：237-240.
19	Liu Z, Jiang XL, Sun CC.Letter: The efficacy and safety of selective granulocyte and monocyte apheresis for inflammatory bowel disease: A meta-analysis[J]. Eur J Intern Med, 2016, 36: e26-e27.

[1]	He Li, Xiaohua Zhou, Xingchao Chen. Clinical analysis of the diagnosis and treatment of early postoperative inflammatory intestinal obstruction, report of 40 cases [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2021, 15(01): 101-103.
[2]	Xin Kong, Baoquan Song, Yin Liu, Jian Zhang, Huiying Qiu, Depei Wu. Intractable hiccup induced by allogeneic hematopoietic stem cell transplantation: a case report [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(04): 253-255.
[3]	Shuang Zhao, Liangming Ma, Qiujuan Zhu, Rong Gong, Zhilin Gao, Weiwei Tian, Tao Wang. Effect of different conditioning regimens on haploid hematopoietic stem cell transplantation in patients with severe aplastic anemia [J]. Chinese Journal of Transplantation(Electronic Edition), 2022, 16(04): 224-230.
[4]	min Chen, Tianzhong Pan, Zimin Sun. Iron removal therapy for poor implantation after allogeneic hematopoietic stem cell transplantation: a case report [J]. Chinese Journal of Transplantation(Electronic Edition), 2022, 16(03): 168-171.
[5]	Jing Zhao, Shuyi Ding, Xiaoyu Zhou, Jianli Zhang, Liwei Xu, Lichen Zhang, Jiali Yan, Qiong Cheng, Nian Liu, Aiyun Jin. The variation and impact factors of quality of life in chronic graft versus host disease patients after allogeneic hematopoietic stem cell transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2022, 16(03): 153-159.
[6]	Heng Liu, Tao Wu. Research progress of ibrutinib in the treatment of chronic graft-versus-host disease [J]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(05): 317-320.
[7]	Yan Liu, Tao Wu, Dongfeng Mao, Lingling Yu, Hai Bai. A case report of human leukocyte antigen matched allogenetic hematopoietic stem cell transplantation in the treatment of refractory polygenic mutation in acute myeloid leukemia [J]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(04): 229-231.
[8]	Chaolang Zhang, Xiaoping Guo, Fenying Zhao, Xiaojun Xu. Infantile diarrhea accompanied with regenerating islet-derived protein 3 alpha elevation after allogeneic hematopoietic stem cell transplantation: two cases report [J]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(02): 116-118.
[9]	Jingsong He, Enfan Zhang, Yi Zhao, Yang Yang, Donghua He, Xiaoyan Han, Gaofeng Zheng, Jingjing Chen, Yi Luo, Jimin Shi, He Huang, Zhen Cai. Efficacy of autologous hematopoietic stem cell transplantation in the treatment of extramedullary multiple myeloma [J]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(02): 93-100.
[10]	Wenhui Liu, Tao Wu, Xi Zhang. Advances in mesenchymal stem cells combined with thrombopoietin receptor agonists in platelet recovery after allogeneic hematopoietic stem cell transplantation [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(04): 242-246.
[11]	Duo Li, Mengjie Huang, Shang Chen, Zongjin Li, Jianwen Chen, Xiangmei Chen. Exploration of the method to transplant mesenchymal stem cells under the capsule of mouse kidney [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2021, 10(06): 323-327.
[12]	Xiang Liao, Shuang Li, Yao Zeng. Analysis of research trends and hotspots of fecal microbiota transplantation from 2012 to 2021 [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(02): 93-99.
[13]	Jie Zhao, Lan Wang, Hongmei Yang, Yi He, Hong Yuan. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in a patient: serological detection methods for mimicking antibodies and blood transfusion strategy [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(05): 452-456.
[14]	Li Xu, Qiuhui Zhang, Ling Zhang, Junying Han, Xinjuan Ma, Xueli Huang. Psychological interventional effects of soul yoga and narrative nursing in patients with hematopoietic stem cell transplantation [J]. Chinese Journal of Clinicians(Electronic Edition), 2021, 15(09): 707-711.
[15]	Shanshan Li, Huizhang Bao, Mei Jia, Chunyan Wang. Clinical significance of serum procalcitonin in patients with infection after hematopoietic stem cell transplantation [J]. Chinese Journal of Clinicians(Electronic Edition), 2021, 15(05): 321-326.

Please choose a citation manager

Content to export